Obama to lift stem cell ban?

Written byAndrea Gawrylewski

| 1 min read

US President-elect Barack Obama is already considering a lift on the current restrictions on embryonic stem cell research, according to a member of Obama's transition team. Yesterday, John Podesta, one of the senior members of Obama's transition team and the previous chief of staff for Bill Clinton, told Fox News Sunday that the transition team is already considering lifting current linkurl:limits on stem cell research,;http://www.the-scientist.com/article/display/53224/ and how Obama can lift several of the other restrictions that linkurl:President George W. Bush;http://www.the-scientist.com/article/daily/24892/ put in place during his administration. In 2001, Bush restricted federal funding for human embryonic stem cells to cell lines that had already been created before August 9, 2001. There are currently linkurl:21 lines;http://www.the-scientist.com/templates/trackable/display/blog.jsp?type=blog&o_url=blog/display/55053&id=55053 that qualify for federal funding. "I think across the board, on stem cell research, on a number of areas," Podesta said, "you see the Bush administration even today moving aggressively to do things that I think are probably not in the interest of the country." Larry Soler, a board member of the Coalition for the Advancement of Medical Research, an umbrella group representing 100 organizations, told linkurl:The New York Times:;http://www.nytimes.com/2008/11/10/us/politics/10obama.html?pagewanted=1&_r=2&ref=us "I think everyone in the scientific community and the patient community is geared up and expecting this and excited to make this happen. It's been a long struggle." Last week, in efforts to move quickly to boost the country's technology sector, Obama recruited several high-level tech-industry minds to join the transition team, including executives from industry investment firms, communications companies, and the Federal Communications Commission.

Obama to lift stem cell ban?

The Scientist ARCHIVES

Become a Member of

Meet the Author

Andrea Gawrylewski

Related Research Resources

A Stubborn Gene, a Failed Experiment, and a New Path

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies